Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy

BACKGROUND AND PURPOSE: Recurrent glioblastoma currently has no established standard of care. We evaluated the response of recurrent glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab by using dynamic susceptibility contrast-enhanced MR perfusion imaging. We hypothesized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AJNR Am J Neuroradiol
Autors principals: Singh, R., Kesavabhotla, K., Kishore, S.A., Zhou, Z., Tsiouris, A.J., Filippi, C.G., Boockvar, J.A., Kovanlikaya, I.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Neuroradiology 2016
Matèries:
Adult Brain
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124417/
https://ncbi.nlm.nih.gov/pubmed/27231225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4823
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars